The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.19.9.282

IN SUMMARY, our early findings seem to justify the following tentative conclusions:

• Intensive time-limited treatment is feasible. Compared with routine hospital treatment, it results in a modest reduction in florid symptoms in a larger number of patients.

• Despite their shorter stay, patients in the brief-treatment group showed no greater rate of readmission, nor was their mean time outside significantly different from that of controls who had received normal hospital care.

• Regardless of the actual number of days of hospitalization, an intensive aftercare program seems to play an important role in reducing or preventing readmissions.

• In trying to determine just how brief a brief inpatient treatment program should be, we must consider a number of reality factors, such as individual differences between patients, patient-staff ratios, difficulties in establishing maximally effective drug dosages, and the availability of community aftercare facilities.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.